Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2681 |
|
| Actual shortage: | 255 (10%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2417 (90%) | |
Discontinuation Reports |
250 |
|
| To be discontinued: | 3 (1%) | |
| Discontinued: | 247 (99%) | |
| Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
23 (9%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-GLICLAZIDE | 80MG | TABLET | Resolved | 2019-07-02 | 2020-07-23 | 88164 |
| RATIO-IPRA SAL UDV | 0.5MG 2.5MG | SOLUTION | Resolved | 2019-07-02 | 2019-07-16 | 88167 |
| TEVA-IRBESARTAN | 300MG | TABLET | Resolved | 2019-07-02 | 2021-09-10 | 88171 |
| TEVA-IRBESARTAN HCTZ | 12.5MG 150MG | TABLET | Resolved | 2019-07-02 | 2019-11-01 | 88174 |
| TEVA-LANSOPRAZOLE | 15MG | CAPSULE (DELAYED RELEASE) | Resolved | 2019-07-02 | 2021-01-28 | 88177 |
| TEVA-LANSOPRAZOLE | 30MG | CAPSULE (DELAYED RELEASE) | Resolved | 2019-07-02 | 2021-01-28 | 88180 |
| TEVA-LANSOPRAZOLE | 30MG | CAPSULE (DELAYED RELEASE) | Resolved | 2019-07-02 | 2021-01-28 | 88183 |
| TEVA-LEFLUNOMIDE | 20MG | TABLET | Resolved | 2019-07-02 | 2019-08-06 | 88186 |
| TEVA-LOSARTAN | 100MG | TABLET | Resolved | 2019-07-02 | 2020-08-21 | 88189 |
| TEVA-LOSARTAN | 100MG | TABLET | Resolved | 2019-07-02 | 2019-11-01 | 88192 |
| TEVA-LOSARTAN | 25MG | TABLET | Resolved | 2019-07-02 | 2020-08-21 | 88195 |
| TEVA-LOSARTAN | 25MG | TABLET | Resolved | 2019-07-02 | 2020-04-23 | 88198 |
| TEVA-LOSARTAN | 50MG | TABLET | Resolved | 2019-07-02 | 2019-11-01 | 88201 |
| TEVA-LOSARTAN | 50MG | TABLET | Resolved | 2019-07-02 | 2019-11-01 | 88204 |
| TEVA-LOSARTAN/HCTZ | 12.5MG 100MG | TABLET | Resolved | 2019-07-02 | 2020-06-18 | 88207 |
| TEVA-LOSARTAN/HCTZ | 25MG 100MG | TABLET | Resolved | 2019-07-02 | 2020-06-25 | 88210 |
| TEVA-OXYCOCET | 325MG 5MG | TABLET | Resolved | 2019-07-02 | 2019-08-10 | 88213 |
| TEVA-PANTOPRAZOLE | 40MG | TABLET (DELAYED-RELEASE) | Resolved | 2019-07-02 | 2021-10-14 | 88216 |
| TEVA-PANTOPRAZOLE | 40MG | TABLET (DELAYED-RELEASE) | Resolved | 2019-07-02 | 2021-10-14 | 88219 |
| TEVA-VARENICLINE | 0.5MG | TABLET | Resolved | 2019-07-24 | 2020-08-04 | 89875 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-ROSUVASTATIN | 40MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157437 |
| PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 0.375G 3G | POWDER FOR SOLUTION | Discontinued | 2023-11-15 | 2023-11-15 | 210191 |
| PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 0.5G 4G | POWDER FOR SOLUTION | Discontinued | 2023-11-15 | 2023-11-15 | 210194 |
| CEFAZOLIN FOR INJECTION | 10G | POWDER FOR SOLUTION | Discontinued | 2023-11-27 | 2023-11-27 | 211558 |
| TEVA-ECTOSONE | 0.1% | LOTION | Discontinued | 2023-12-05 | 2023-12-05 | 212526 |
| TEVA-DICLOFENAC EC | 25MG | TABLET (ENTERIC-COATED) | Discontinued | 2024-01-25 | 2024-01-26 | 217254 |
| TEVA-IRBESARTAN | 75MG | TABLET | Discontinued | 2024-04-01 | 2024-04-01 | 224049 |
| VINORELBINE TARTRATE FOR INJECTION | 10MG | SOLUTION | To be discontinued | 2019-07-05 | 2019-07-05 | 88619 |
| ACT CELECOXIB | 100MG | CAPSULE | To be discontinued | 2020-09-03 | 2020-09-03 | 123648 |
| ACT CELECOXIB | 200MG | CAPSULE | To be discontinued | 2020-09-03 | 2020-09-03 | 123651 |